What is a realistic timeline for completing a trial on 140 critical? Given only 62 were enrolled through CD12, and only 5 in OLE (my interpretation of NP saying 20% death rate and one dead in critical OLE). Factoring in the protocol is not yet accepted, enrollment, study period, analysis, then FDA decision... I am not seeing how 3 months is possible without help of some sort. And of course, vaccine rollout particularly in vulnerable populations at this point makes it even harder.